<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vimala Yerramilli</style></author><author><style face="normal" font="default" size="100%">Mahendra Singh</style></author><author><style face="normal" font="default" size="100%">Ishwar Singh</style></author><author><style face="normal" font="default" size="100%">Laxman Nagar</style></author><author><style face="normal" font="default" size="100%">Jitendra Singh</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hepato-restorative Activity of Methanolic Extracts of Coccinia grandis L. Voigt. in CCl4 - Intoxicated Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Callus</style></keyword><keyword><style  face="normal" font="default" size="100%">CCl4</style></keyword><keyword><style  face="normal" font="default" size="100%">Coccinia grandis</style></keyword><keyword><style  face="normal" font="default" size="100%">GC-MS</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1096-1102</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;&lt;em&gt;Coccinia grandis&lt;/em&gt; has pharmacological activities such as antioxidant, anti-ulcer, antiinflammatory, anti-hypersensitive, anti-hyperglycaemic, anti-cancer and hepatoprotective.&lt;strong&gt; Objective: &lt;/strong&gt;This work is aimed to investigate an alternative low-cost green drug with hepatoprotective potential from methanolic extract of the leaf, stem and their corresponding calli of &lt;em&gt;Coccinia grandis&lt;/em&gt;. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Using 42 Albino Wistar rats divided into seven groups each group containing 6 rats. 1.5ml/kg bw of CCl&lt;sub&gt;4&lt;/sub&gt; diluted in olive oil was orally injected for fourteen days and methanolic extracts of parent plant parts, callus and silymarin, and on the last day of treatment, experimental rats were anesthetized, blood and organ removed for the biochemical and histopathological analysis.&lt;strong&gt; Results:&lt;/strong&gt; This work is aimed to investigate an alternative low-cost green drug with hepatoprotective potential. Liver damage was induced by CCl&lt;sub&gt;4&lt;/sub&gt; (1.5 ml/kg body weight) in Wistar albino rats and recovery was noted by treating with Silymarin (100mg/kg bw), a known standard herbal drug and by treating with crude methanolic extract of leaf and stem parts of &lt;em&gt;Coccinia grandis&lt;/em&gt; and their corresponding calli (leaf callus and stem callus at 180mg/kg bw) in terms of marked decrease in CCl&lt;sub&gt;4-&lt;/sub&gt; increased SGOT (Serum glutamic oxaloacetic transaminase), SGPT (Serum glutamic pyruvic transaminase), ALP (Alkaline phosphatase), TB (Total bilirubin) and rise in TP (Total protein) compared to untreated control group. Histopathological studies of hepatocytes provide evidence of the centrilobular vacuolar degeneration and recovery by Silymarin or treatment with plant and callus extracts. &lt;strong&gt;Conclusion:&lt;/strong&gt; Biochemical and histopathological examination proved the hepatoprotective potential of calli and parent plant parts (leaf, stem) of &lt;em&gt;Coccinia grandis&lt;/em&gt;.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1096</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Vimala Yerramilli&lt;sup&gt;1*&lt;/sup&gt;, Mahendra Singh&lt;sup&gt;1&lt;/sup&gt;,Ishwar Singh&lt;sup&gt;2&lt;/sup&gt;, Laxman Nagar&lt;sup&gt;3&lt;/sup&gt;, Jitendra Singh&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1,2&lt;/sup&gt;,Department of Botany, Chaudhary Charan Singh, University, Meerut, 250004-INDIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1, 3,4&lt;/sup&gt;Department of Microbiology, Chaudhary Charan Singh, University, Meerut, 250004-INDIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jimenez-Arellanes Maria Adelina</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Studies of Silymarin as a Protective Agent Against Liver Damage Caused by Anti-TB Drugs, Methotrexate, and in Cases of Chronic Hepatitis C and Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-TB drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatoprotector</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Methotrexate</style></keyword><keyword><style  face="normal" font="default" size="100%">Nephroprotector</style></keyword><keyword><style  face="normal" font="default" size="100%">Silybin</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">358-368</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The liver is the organ in charge of homeostasis and metabolism of sundry substances (endogenous and exogenous, including drugs); but when these are metabolized, they generate more toxic and/or reactive metabolites, that can damage the liver causing cirrhosis, steatosis and/or hepatocarcinoma. Human have been used several medicinal plants (MP) since ancestral times to treat their ailments, diseases and liver disorders, including&lt;em&gt; Sylibum marianum&lt;/em&gt;. This MP is used in the treatment of jaundice and other biliary diseases, as well as in support therapy for edible mushrooms poisoning and in the treatment of some hepatic diseases. From this medicinal plant, silymarin (SLM, mixture of flavonoids) is obtained, it has an important antioxidant, anti-inflammatory and hepatoprotector effect. The last activity has been demonstrated through several preclinical and in some clinical studies. To date, a few clinical studies describe the hepatoprotective and/or nephroprotective effect of SLM against the damage caused by anti- TB drugs, methotrexate and in cases of type II diabetes mellitus or chronic hepatitis C. Nevertheless, this type of research is more frequent in preclinical trials (using rats or mice) or in vitro assay.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">358</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Jimenez-Arellanes Maria Adelina&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Unidad de Investigación Médica en Farmacología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Col. Doctores, Delg, Cuauhtémoc 06720, CDMX, MEXICO.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noor Ahmed Abed</style></author><author><style face="normal" font="default" size="100%">Musab Mohammed Khalaf</style></author><author><style face="normal" font="default" size="100%">Mohammed Khalid Jamaludeen Alnori</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%"> The Potential Effect of Silymarin Against Paracetamol-Induced Hepatotoxicity in Male Albino Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">APAP</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">NAC</style></keyword><keyword><style  face="normal" font="default" size="100%">Paracetamol</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-α</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">558-564</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background&lt;/strong&gt;: Being the main metabolic organ, liver stays in touch with toxicity of introduced materials including, drugs. Protection is priceless to avoid complication of liver toxicity. &lt;strong&gt;Objectives&lt;/strong&gt;: This research aimed to assess the protective impact of silymarin (SIL) on hepatotoxicity based on acute paracetamol (APAP) intoxication in rats in comparison with N-acetylcysteine (NAC). &lt;strong&gt;Methods: &lt;/strong&gt;To do so serum was collected and the liver was analyzed for histological findings on rat model-paracetamol toxicity whether alone or in combination with SIL or NAC. The scenario was based on either preconditioning with SIL/NAC before induction of toxicity or afterwards. Serum liver function tests, pro-oxidant/antioxidant status, and proinflammatory markers were detected alongside liver histological study. &lt;strong&gt;Results: &lt;/strong&gt;The results showed that liver function indices, oxidative state, and pro-inflammatory parameters were significantly changed, and histopathological alterations were detected in the liver of the intoxicated group. These modifications were inverted in groups treated with either SIL or NAC. The results of the current study suggested that SIL might be employed as a hepatoprotective drug against liver damage induced by APAP because of its ability to reduce lipid peroxidation, improve antioxidant defense status, and have anti-inflammatory effects.&lt;strong&gt; Conclusion:&lt;/strong&gt; These results are equivalent to NAC therapy which is a standard drug against APAPrelated hepatotoxicity.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">558</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Noor Ahmed Abed&lt;sup&gt;1&lt;/sup&gt;, Musab Mohammed Khalaf&lt;sup&gt;1&lt;/sup&gt;, Mohammed Khalid Jamaludeen Alnori&lt;sup&gt;2,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology and Toxicology, College of Pharmacy, University of Mosul, IRAQ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Clinical Laboratory Sciences, College of Pharmacy, University of Mosul, IRAQ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Thanh Ha Tuan Nguyen</style></author><author><style face="normal" font="default" size="100%">Ngan Nguyen Hoang</style></author><author><style face="normal" font="default" size="100%">Xuan Thanh Nguyen</style></author><author><style face="normal" font="default" size="100%">Binh Nhu Do</style></author><author><style face="normal" font="default" size="100%">Son Trinh The</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluate the Effect of Herbal Extract Remedy for Treatment of Liver Cirrhosis in in-vitro</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">CCl4</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver cirrhosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar Rats</style></keyword><keyword><style  face="normal" font="default" size="100%">XGTQ herbal extract</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">189-195</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objectives:&lt;/strong&gt; To evaluate the in-vitro effect of herbal extract recepies, namely XGTQ, in the treatment of liver cirrhosis that induced by Carbon tetrachloride (CCL4) in combination with alcohol and high-fat diet in rats. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Liver cirrhosis was induced by subcutaneously injecting CC14 (initial dose of 5,0ml/kg, followed by 1,2ml/kg twice a week in 10 weeks) in winstar rats. Then, fed with synthetic food, added 20% fat, and 0.05% cholesterol and iron oxalate. Rats were administered a day with fresh water and water mixed with 30% ethanol in another day. The rats were randomly divided into 5 groups and given distilled water (group 1 or control group and group 2 or cirrhosis group), silymarin (group 3 or reference group) or the herbal recipes, aka XGTQ, drug extract (group 4, 5) for 4 weeks. Blood was collected for biochemical test and livers were dissected to evaluate weight, morphology and quantified 4-hydroxyproline to evaluate fibrosis and collagen accumulation.&lt;strong&gt; Results: &lt;/strong&gt;In cirrhotic wistar rats, the XGTQ herbal drug at 19.6 g/kg/24h and 58.8 g/kg/24h showed the ability of reducing the level of enzymes AST, ALT in the blood (p&amp;lt;0.01), increasing plasma albumin and decreasing prothrobin time (p&amp;lt;0.05); improving physical condition, macroscopic and microscopic images of H&amp;amp;E-stained liver; decreasing the concentration of hydroxyproline in the liver and reducing the level of cirrhosis on the masson-stained templates. The effect of herbal recipes XGTQ increased dramatically with the dose, and was equivalent to silymarin at the dose of 70 mg/kg/24h. &lt;strong&gt;Conclusion: &lt;/strong&gt;The aqueous extract of XGTQ herbal remedy has have a good effect in treatment of liver cirrhosis in in-vitro and to be equivalent to that of silymarin at the dose of 70 mg/kg.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">189</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Thanh Ha Tuan Nguyen&lt;sup&gt;1,2,#&lt;/sup&gt;, Ngan Nguyen Hoang&lt;sup&gt;1,#&lt;/sup&gt;, Xuan Thanh Nguyen&lt;sup&gt;1,2&lt;/sup&gt;, Binh Nhu Do&lt;sup&gt;1,2&lt;/sup&gt;, Son Trinh The&lt;sup&gt;1,&lt;/sup&gt;* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Vietnam Military Medical University, No.160 Phung Hung st, Phuc La, Ha dong, Ha noi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Military Hospital 103, No.261 Phung Hung st, Phuc La, Ha Dong, Ha Noi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;#&lt;/sup&gt;These authors contributed equally to this work and are co‐first authors&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">G Tharun</style></author><author><style face="normal" font="default" size="100%">S Sivakrishnan</style></author><author><style face="normal" font="default" size="100%">JVC Sharma</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Toxicity Assessment, Evaluation of Antioxidant and Hepatoprotective Activity on Cordia obliqua Fruit Extracts</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cordia obliqua</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Paracetamol</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1005-1011</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;&lt;em&gt;Cordia obliqua &lt;/em&gt;Willd plant is a genus of flowering plants in the borage family, Boraginaceae. It is also known as clammy cherry. Very little research was carried out for identification of its medicinal importance when compared to other Cordia species&lt;strong&gt; Objective: &lt;/strong&gt;To determine the safe dose and to explore the in vivo antioxidant and hepatoprotective activity of &lt;em&gt;Cordia obliqua &lt;/em&gt;fruits &lt;strong&gt;Methods:&lt;/strong&gt; As per our previous study the ethanolic and aqueous extracts were rich in phytoconstituents and exhibited good in vitro antioxidant effect. So the ethanolic and aqueous extracts were used for evaluation of activity. Acute toxicity study (LD&lt;sub&gt;50&lt;/sub&gt;) was conducted according to OECD guidelines. For hepatoprotective activity paracetamol induced hepatotoxicity was studied using standard drug like Silymarin. The antioxidant potential] of the plant extracts were tested using three tests viz, Reduced GSH, Catalase and SOD activity &lt;strong&gt;Results: &lt;/strong&gt;Acute toxicity studies showed the non-toxic nature of &lt;em&gt;Cordia obliqua&lt;/em&gt; fruit extract upto dose of 3000mg/kg body weight. Administration of Paracetamol to rats increased the levels of marker enzymes like ALT, AST and ALP. Increase in the levels of these enzymes in serum indicates damage to the liver cells. Pretreatment with aqueous and ethanolic extracts of &lt;em&gt;Cordia obliqua &lt;/em&gt;decreased the levels of ALT, AST, ALP and increased levels of total protein, total bilirubin, direct bilirubin and comparisons histology of cells of extract which are an indication for the hepatoprotective activity. &lt;strong&gt;Conclusion: &lt;/strong&gt;The fruits of &lt;em&gt;Cordia obliqua&lt;/em&gt; are safe and effective in treatment of hepatic disorders and prevent oxidation of cells.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1005</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;G Tharun&lt;sup&gt;1,&lt;/sup&gt;*, S Sivakrishnan&lt;sup&gt;2&lt;/sup&gt;, JVC Sharma&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;PhD Research Scholar of Department of Pharmacy, Annamalai University, Chidambaram and Asst. Professor, University College of Pharmaceutical Sciences, Palamuru University, Mahabubnagar, Telangana, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Assistant Professor, Department of Pharmacy, FEAT, Annamalai University, Annamalai Nagar, Chidambaram, Tamilnadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Professor and Principal, Joginpally B.R Pharmacy College, Yenkapally, Moinabad, R.R. Dist. Telangana, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>